First, 41 non-ccRCC and 19 NAT samples were enriched for N-glycopeptides,61 analyzed by MSFragger-Glyco search pipeline62,63 (STAR Methods). This evidence concerns the gene BRD2 and nonpapillary renal cell carcinoma.